Sort
82,697 grants matching “vaccine development”
Malaria parasite determinants of host cell tropism
$816,073Manoj T Duraisingh · Harvard School Of Public Health · R01 · FY2023 · AI
Early Events in Mucosal SIV Pathogenesis
$816,065Ronald S. Veazey · Tulane University Of Louisiana · R01 · FY2011 · AI
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
$815,922Pia S Pannaraj · University Of California, San Diego · R01 · FY2025 · AI
Mechanisms of SARS-CoV-2 pathogenesis during HIV/SIV infection
$815,811Megan A O'Connor · University Of Washington · R01 · FY2023 · HL
Harnessing CD4+ T cell responses for long-term protective immunity against HIV
$815,810Rafi Ahmed · Scripps Research Institute, The · UM1 · FY2017 · AI
Development of a thermostable rotavirus vaccine for mucosal delivery withoutneed for reconstitution - Phase II
$815,746Victor Bronshtein · Universal Stabilization Technologies · R44 · FY2018 · AI
Optimizing Adjuvants and Needle Free Delivery Methods for Oral HIV Vaccination
$815,685Rama Rao Amara · Emory University · R01 · FY2019 · DE
Clonal Dynamics of HIV/SIV-specific T cells
$815,584Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Tulane/LSU Pediatric AIDS Clinical Trials Unit
$815,476Tulane University Of Louisiana · U01 · FY2002 · AI
Exploratory Human Trials of Combination Rectal Microbicides
$815,201Ian Michael McGowan · Magee-Women'S Res Inst And Foundation · U19 · FY2011 · AI
Mapping and dissecting the role of antibodies in Mtb control
$815,165Galit Alter · Massachusetts General Hospital · R56 · FY2020 · AI
Mechanisms of SIV suppression by CD8+ lymphocytes
$814,996Guido Silvestri · Emory University · R01 · FY2011 · AI
ACTIVITY 3: TROPICAL INFECTIOUS DISEASES DETECTION AND PREVENTION
$814,974Vivek Ramchandra Nerurkar · University Of Hawaii At Manoa · G12 · FY2009 · RR
Technology Development for 3D Electron Microscopy
$814,930Sriram Subramaniam · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
HIV neutralization and mechanisms of cellular entry
$814,930Sriram Subramaniam · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Task X21: Preparedness for Testing NIAID Priority Vaccines in General Safety and Toxicology Studies
$814,926Randi Hornback · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2020 · AI
Immunogenetics of COVID-19 Immune Response
$814,873Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2024 · AI
Vaccines to Induce Functional Antibodies Targeting the V2 Loop
$814,846Susan B Zolla-Pazner · New York University School Of Medicine · P01 · FY2017 · AI
Integrated genomics research in parasitic tropical diseases
$814,735Joana Carneiro Da Silva · University Of Maryland Baltimore · U19 · FY2017 · AI
Balancing epithelial cell resistance and resilience to respiratory viral infections
$814,724Jose Manuel Ordovas-Montanes · Boston Children'S Hospital · R01 · FY2024 · HL
Antibody Responses in Aging SIV Infected Monkeys
$814,638Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2016 · AI
Optical Chip Test for T Cell Function in HIV Patients
$814,595Ngimat Company · R44 · FY2005 · AI
Administrative Core
$814,589Lawrence S Sturman · Wadsworth Center · U54 · FY2008 · AI
GBS mediated in utero fetal injury
$814,572Lakshmi Rajagopal · Seattle Children'S Hospital · R01 · FY2012 · AI
Tulane/LSU Pediatric AIDS Clinical Trials Unit
$814,570Tulane University Of Louisiana · U01 · FY2003 · AI